CLASS II Drug recall · Reported 19 Aug 2015 · FDA Enforcement Report

9% Sodium Chloride Injection USP in Viaflex recalled

Baxter Healthcare is recalling 9% Sodium Chloride Injection USP in Viaflex, Baxter Healthcare Corporation Deerfield, IL, distributed in Tennessee, Texas. The recall was initiated on 2 Jul 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: C964601, Exp 4/30/2016
NDC0338-0043, 0338-0049
Quantity recalled189,912 containers

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1326-2015
FDA event ID
71627
Recalling firm
Baxter Healthcare, Deerfield, IL
Manufacturer
Baxter Healthcare Corporation
Classification
Class II
Status
Terminated
Recall initiated
2 Jul 2015
FDA classified
12 Aug 2015
Reported
19 Aug 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

2 Jul 2015Recall initiated by company
12 Aug 2015Classified by FDA+41 days
19 Aug 2015Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter and Lack of Assurance of Sterility: The firm received a complaint for customer of presence of particulate matter, leaky containers, and missing port protectors.

Product as listed by the FDA

0.9% Sodium Chloride Injection USP, 500 mL in VIAFLEX Plastic Container, Baxter Healthcare Corporation Deerfield, IL 60015, NDC 0338-0049-03.

Where it was distributed

TX and TN

TennesseeTexas

Questions about this recall

Is 9% Sodium Chloride Injection USP in Viaflex, Baxter Healthcare Corporation Deerfield, IL recalled?

Yes. Baxter Healthcare recalled 9% Sodium Chloride Injection USP in Viaflex, Baxter Healthcare Corporation Deerfield, IL on 2 Jul 2015. The recall is Class II and its status is Terminated. Recall number D-1326-2015.

Why was it recalled?

Presence of Particulate Matter and Lack of Assurance of Sterility: The firm received a complaint for customer of presence of particulate matter, leaky containers, and missing port protectors.

Which lots are affected?

Lot #: C964601, Exp 4/30/2016

Where was it sold?

TX and TN

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Baxter Healthcare

All 564

Other Sodium Chloride recalls

All 76